Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study

Bone-modifying agents (BMA) such as bisphosphonates and denosumab are frequently used for the treatment of bone metastases, osteoporosis, and multiple myeloma. BMA may lead to anti-resorptive agent-related osteonecrosis of the jaw (ARONJ). This study aimed to clarify the risk factors for and probabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Rieko, Sukegawa, Shintaro, Sukegawa, Yuka, Hasegawa, Kazuaki, Ono, Sawako, Nakamura, Tomoya, Fujimura, Ai, Fujisawa, Ayaka, Nakano, Keisuke, Takabatake, Kiyofumi, Kawai, Hotaka, Nagatsuka, Hitoshi, Furuki, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317393/
https://www.ncbi.nlm.nih.gov/pubmed/35885858
http://dx.doi.org/10.3390/healthcare10071332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317393/
https://www.ncbi.nlm.nih.gov/pubmed/35885858
http://dx.doi.org/10.3390/healthcare10071332

Ejemplares similares